|
Status |
Public on Feb 15, 2020 |
Title |
19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis |
Organism |
Homo sapiens |
Experiment type |
Genome variation profiling by array
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
This study includes 208 neuroblastoma tumors obtained by array-CGH assay were used to verify if 19p loss is significantly over-represented in children and adolescents. Refer to individual Series
|
|
|
Citation(s) |
32337068 |
|
Submission date |
Feb 14, 2020 |
Last update date |
May 19, 2020 |
Contact name |
Annalisa Pezzolo |
E-mail(s) |
annalisapezzolo@gaslini.org
|
Organization name |
IRCCS Istituto Gaslini
|
Lab |
Laboratorio Cellule Staminali e Terapie Cellulari
|
Street address |
Via Gerolamo Gaslini, 3
|
City |
Genova |
ZIP/Postal code |
16147 |
Country |
Italy |
|
|
Platforms (4)
|
GPL2879 |
Agilent-013282 Human Genome CGH Microarray 44B (Feature number version) |
GPL5477 |
Agilent-014950 Human Genome CGH Microarray 4x44K (Feature Number version) |
GPL10123 |
Agilent-022060 SurePrint G3 Human CGH Microarray 4x180K (Feature Number version) |
GPL16237 |
Agilent-030587 CCMC CGH plus SNP 180k Microarray |
|
Samples (208)
|
|
This SuperSeries is composed of the following SubSeries:
|
GSE145336 |
19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis (Agilent-013282, dataset 1) |
GSE145337 |
19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis (Agilent-013282, dataset 2) |
GSE145338 |
19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis (Agilent-014950) |
GSE145339 |
19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis (Agilent-030587) |
GSE145340 |
19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis (Agilent-022060) |
|
Relations |
BioProject |
PRJNA606780 |